Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADA | P00813 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | STAT6 | P42226 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | ATG7 | O95352 | 1/20 | 0.51 |
| ▸ | ADK | P55263 | 6/20 | 0.49 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.48 |
| ▸ | DCLK1 | O15075 | 1/20 | 0.48 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.48 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.48 |
| ▸ | CDK1 | P06493 | 1/20 | 0.48 |
| ▸ | ROS1 | P08922 | 1/20 | 0.48 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.48 |
| ▸ | CDK2 | P24941 | 1/20 | 0.48 |
| ▸ | FLT3 | P36888 | 1/20 | 0.48 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.48 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.48 |
| ▸ | CLK2 | P49760 | 1/20 | 0.48 |
| ▸ | IRAK1 | P51617 | 1/20 | 0.48 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29601078 | 0.89 | ATG7 (0.53) | ADASTAT6HIF1AATG7ADK | |
| SCHEMBL29600893 | 0.89 | ADK (0.58) | ADAATG7ADK | |
| SCHEMBL29325559 | 0.85 | ADA (0.54) | ADASTAT6ATG7ADKDOT1L | |
| SCHEMBL29323419 | 0.85 | ADA (0.54) | ADASTAT6ATG7ADKDOT1L | |
| SCHEMBL11672972 | 0.85 | ADA (0.54) | ADASTAT6ATG7ADKDOT1L | |
| SCHEMBL6672454 | 0.85 | ADA (0.54) | ADASTAT6ATG7ADKDOT1L | |
| SCHEMBL6671707 | 0.85 | ADA (0.54) | ADASTAT6ATG7ADKDOT1L | |
| SCHEMBL11327761 | 0.85 | ADA (0.54) | ADASTAT6ATG7ADKDOT1L | |
| SCHEMBL11207738 | 0.85 | ADA (0.54) | ADASTAT6ATG7ADKDOT1L | |
| SCHEMBL8975931 | 0.84 | ADK (0.71) | ADKSMN1; SMN2LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114450265-B | Cationic lipids and uses thereof | 菲克特生物科学股份有限公司 | 2024-12-24 | — | — | CN | claimed |
| EP-4705273-A2 | MULTIVALENT IONIZABLE LIPID DELIVERY SYSTEMS | Factor Bioscience Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-4673226-A1 | RNA-BASED INHIBITORS OF TRNA MODIFYING ENZYMES | Yale University (US) | 2026-01-07 | — | — | EP | disclosed |
| EP-4673165-A1 | INTERLEUKIN-2 AND INTERLEUKIN-12 FOR CANCER THERAPY | KRYSTAL BIOTECH, INC. (US) | 2026-01-07 | — | — | EP | disclosed |
| WO-2024182707-A9 | INTERLEUKIN-2 AND INTERLEUKIN-12 FOR CANCER THERAPY | Krystal Biotech, Inc. (US) | 2024-12-05 | — | — | WO | disclosed |
| WO-2024229032-A2 | MULTIVALENT IONIZABLE LIPID DELIVERY SYSTEMS | FACTOR BIOSCIENCE INC. (US) | 2024-11-07 | — | — | WO | disclosed |
| EP-4429641-A1 | BIOMARKERS OF MEGAKARYOCYTE-DERIVED EXTRACELLULAR VESICLES | STRM.Bio Incorporated (US) | 2024-09-18 | — | — | EP | disclosed |
| WO-2024182707-A1 | INTERLEUKIN-2 AND INTERLEUKIN-12 FOR CANCER THERAPY | Krystal Biotech, Inc. (US) | 2024-09-06 | — | — | WO | disclosed |
| WO-2024182719-A1 | RNA-BASED INHIBITORS OF TRNA MODIFYING ENZYMES | YALE UNIVERSITY (US) | 2024-09-06 | — | — | WO | disclosed |
| EP-4329799-A1 | MESSENGER RNA THERAPEUTICS AND COMPOSITIONS | Greenlight Biosciences, Inc. (US) | 2024-03-06 | — | — | EP | disclosed |
| WO-2023205424-A2 | LIPID COMPOSITIONS AND METHODS FOR NUCLEIC ACID DELIVERY | GREENLIGHT BIOSCIENCES, INC. (US) | 2023-10-26 | — | — | WO | disclosed |
| EP-4182332-A1 | NUCLEIC ACID THERAPEUTICS FOR GENETIC DISORDERS | Greenlight Biosciences, Inc. (US) | 2023-05-24 | — | — | EP | disclosed |
| WO-2023086590-A1 | METHODS RELATED TO MEGAKARYOCYTE-DERIVED EXTRACELLULAR VESICLES | STRM.BIO INCORPORATED (US) | 2023-05-19 | — | — | WO | disclosed |
| WO-2023086595-A1 | BIOMARKERS OF MEGAKARYOCYTE-DERIVED EXTRACELLULAR VESICLES | STRM.BIO INCORPORATED (US) | 2023-05-19 | — | — | WO | disclosed |
| WO-2022232687-A1 | MESSENGER RNA THERAPEUTICS AND COMPOSITIONS | GREENLIGHT BIOSCIENCES, INC. (US) | 2022-11-03 | — | — | WO | disclosed |